Today, organizations worldwide are revamping their research and development engines, adding decentralized capabilities to their traditional suite of services. As an industry leader and pioneer in decentralized trials, Medable has developed a robust readiness framework that we use when assessing protocol-fit readiness for optimized DCT design with our clients. Join Rasmus Hogreffe and Andrew Mackinnon, as they uncover what it takes for organizations to be “ready” for the future of DCT. Attendees will walk away with an understanding of:
Rasmus Hogreffe, MSc.Med., MBA is considered as a Virtual Clinical Trials expert. His main goal is to improve treatment for patients by...
.png)
Experienced drug development professional with a demonstrated history of working across multiple business areas within the research industry